Cargando…
The miRNA-184 drives renal fibrosis by targeting HIF1AN in vitro and in vivo
Progressive renal fibrosis is the last phase of chronic kidney disease and results in renal failure. Micro-RNA has been demonstrated as important agent to drive organ fibrosis. However, the precise mechanisms are not fully understood. Here, we found miRNA-184 as a critical mediator to promote the re...
Autor principal: | Chen, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424919/ https://www.ncbi.nlm.nih.gov/pubmed/30536131 http://dx.doi.org/10.1007/s11255-018-2025-4 |
Ejemplares similares
-
miRNA biomarkers in renal disease
por: Franczyk, Beata, et al.
Publicado: (2021) -
Blood TGF-β1 and miRNA-21-5p levels predict renal fibrosis and outcome in IgA nephropathy
por: Bharti, Niharika, et al.
Publicado: (2023) -
microRNA-29b prevents renal fibrosis by attenuating renal tubular epithelial cell–mesenchymal transition through targeting the PI3K/AKT pathway
por: Hu, Shuang, et al.
Publicado: (2021) -
MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy
por: Zanchi, Cristina, et al.
Publicado: (2017) -
The ratio of urinary TREM-1/TREM-2 mRNA expression in chronic kidney disease and renal fibrosis
por: Cao, Yuhan, et al.
Publicado: (2021)